Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ethinylest 33.9microg/Norelgestromin 203microg/24hours ptch
0703010E0AAAEAE
|
Combined ethinylestradiol 20mcg | Combined ethinylestradiol 20mcg | Obstetrics, Gynaecology and Urinary-Tract Disorders | 7,202 |
|
Ethinylestradiol 20microgram / Desogestrel 150microgram tab
0703010E0AAABAB
|
Combined ethinylestradiol 20mcg | Combined ethinylestradiol 20mcg | Obstetrics, Gynaecology and Urinary-Tract Disorders | 5,107 |
|
Ethinylestradiol 20microgram / Gestodene 75microgram tablets
0703010E0AAACAC
|
Combined ethinylestradiol 20mcg | Combined ethinylestradiol 20mcg | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,881 |
|
Ethinylestradiol 20microgram / Drospirenone 3mg tablets
0703010E0AAAFAF
|
Combined ethinylestradiol 20mcg | Combined ethinylestradiol 20mcg | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,812 |
|
Ethinylestradiol 20microg / Norethisterone acetate 1mg tab
0703010E0AAAAAA
|
Combined ethinylestradiol 20mcg | Combined ethinylestradiol 20mcg | Obstetrics, Gynaecology and Urinary-Tract Disorders | 4 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.